Context: Mitotane plasma concentrations ≥ 14 mg/l have been shown to predict tumor response and better survival in patients with advanced adrenocortical carcinoma (ACC). A correlation between mitotane concentrations and patient outcome has not been demonstrated in an adjuvant setting.
Objective: To compare recurrence-free survival (RFS) in patients who reached and maintained mitotane concentrations ≥ 1 4 mg/l vs patients who did not.
Design And Setting: Retrospective analysis at six referral European centers.
Patients: Patients with ACC who were radically resected between 1995 and 2009 and were treated adjuvantly with mitotane targeting concentrations of 14-20 mg/l.
Main Outcome Measures: RFS (primary) and overall survival (secondary).
Results: Of the 122 patients included, 63 patients (52%) reached and maintained during a median follow-up of 36 months the target mitotane concentrations (group 1) and 59 patients (48%) did not (group 2). ACC recurrence was observed in 22 patients of group 1 (35%) and 36 patients in group 2 (61%). In multivariable analysis, the maintenance of target mitotane concentrations was associated with a significantly prolonged RFS (hazard ratio (HR) of recurrence: 0.418, 0.22-0.79; P=0.007), while the risk of death was not significantly altered (HR: 0.59, 0.26-1.34; P=0.20). Grades 3-4 toxicity was observed in 11 patients (9%) and was managed with temporary mitotane discontinuation. None of the patients discontinued mitotane definitively for toxicity.
Conclusions: Mitotane concentrations ≥ 14 mg/l predict response to adjuvant treatment being associated with a prolonged RFS. A monitored adjuvant mitotane treatment may benefit patients after radical removal of ACC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1530/EJE-13-0242 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Land use and occupation and pesticide contamination assessment in honey from Africanized honey bees (Hymenoptera: Apidae) using gas chromatography-mass spectrometry.
An Acad Bras Cienc
October 2024
Universidade Estadual do Oeste do Paraná/UNIOESTE, Centro de Ciências Agrárias, Rua Pernambuco, 1777, 85960-000 Marechal Cândido Rondon, PR, Brazil.
We examined pesticide contamination in honey from Africanized honey bees in two different seasons, and evaluated the concentration and incidence of these compounds in georeferenced apiaries to provide relevant information for food safety and environmental quality. The land use and occupation of the region were evaluated by selecting 15 apiaries and georeferencing three randomly selected colonies of Africanized honey bees within each apiary. Honey samples were collected during two seasons, and three organochlorine pesticides (p.
View Article and Find Full Text PDFDevelopment and validation of a liquid chromatography coupled to a diode array detector (LC-DAD) method for measuring mitotane (DDD) in plasma samples.
Clinics (Sao Paulo)
August 2024
Laboratório de Hormônios e Genética Molecular LIM-42, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil; Núcleo Multiusuário de Cromatografia Líquida Associada à Espectrometria de Massas em Tandem, (AE-06 Rede Premium), Brazil. Electronic address:
Article Synopsis
- Mitotane is the primary medication for Adrenocortical Carcinomas (ACC), and effective plasma measurement is crucial for treatment control.
- A new method was developed to measure mitotane in plasma using HPLC with a specific internal standard and detailed procedural steps for sample preparation.
- The results showed high sensitivity, accuracy, and minimal interference from other plasma compounds, confirming that the method is reliable for monitoring mitotane levels.
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.
Lancet Oncol
May 2024
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Background: Adrenocortical carcinoma is a rare malignancy with poor response to systemic chemotherapy. Mitotane is the only approved therapy for adrenocortical carcinoma. Cabozantinib is a multikinase inhibitor approved in multiple malignancies.
View Article and Find Full Text PDFResidual levels, phase distributions, and human health risks of OCPs in the middle reach of the Huai River, China.
Environ Sci Pollut Res Int
March 2024
Anhui Provincial Engineering Laboratory of Water and Soil Pollution Control and Remediation, School of Ecology and Environment, Anhui Normal University, Wuhu, Anhui, 241002, People's Republic of China.
Are the residues of organochlorine pesticides (OCPs) in freshwater in China still of concern after prohibition and restriction for decades? The scarcity of monitoring data on OCPs in freshwater in China over the past few years has hampered understanding of this issue. In this study, water and suspended particulate matter (SPM) samples were collected from the middle reach of the Huai River for OCP analyses. Residues of ∑OCPs in water and SPM ranged from ND to 8.
View Article and Find Full Text PDFWnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma.
Front Endocrinol (Lausanne)
January 2024
Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Tongji Shanxi Hospital, Taiyuan, China.
Adrenocortical carcinoma (ACC) is an uncommon, aggressive endocrine malignancy with a high rate of recurrence, a poor prognosis, and a propensity for metastasis. Currently, only mitotane has received certification from both the US Food and Drug Administration (FDA) and the European Medicines Agency for the therapy of advanced ACC. However, treatment in the advanced periods of the disorders is ineffective and has serious adverse consequences.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!